Clinical Trials Browser

Observation × Thoracic × Clear all

NCT04267848 2026-04-15

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06498635 2026-04-14

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02193282 2026-04-13

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT02194738 2026-04-13

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Phase NA Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02595944 2026-04-13

ANVIL

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07388524 2026-04-13

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05257551 2026-04-02

TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)

Neoplasms, Small Cell Lung Carcinoma

NCT07472478 2026-03-16

GIVEN

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05236114 2026-02-05

GEMINI-NSCLC: NSCLC Biomarker Study

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT07239544 2025-11-20

Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines

Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06192004 2025-06-03

LOOP

Carcinoma, Non-Small-Cell Lung, Pneumonia, Lung Diseases, Interstitial

NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study

Active not recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06743555 2024-12-20

SAVED LUNG

Phase 1 Not yet recruiting

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT06008353 2024-12-19

EDUR-BRA

Active not recruiting

Small Cell Lung Carcinoma

NCT06730477 2024-12-12

Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma

Enrolling by invitation

Adenocarcinoma of Lung

NCT01725165 2024-10-24

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Phase 2 Completed

85 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT04566432 2024-07-18

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06448455 2024-06-10

Observation on the Frailty Status of Lung Cancer Patients

Frailty, Lung Neoplasms

NCT04085250 2024-04-23

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05857800 2023-06-08

NAT-LungMate

Lung Neoplasms

NCT05032352 2022-11-14

PADMA

Carcinoma, Non-Small-Cell Lung

NCT03770299 2022-03-24

CheckMate 9TN

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT05082636 2021-10-25

The Role of Programmed Death Ligand -1 (Pdl-1) in Lung Cancer

Lung Neoplasms

NCT05066945 2021-10-04

Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients

Not yet recruiting

Small Cell Lung Cancer Extensive Stage

NCT02073500 2021-07-28

PSM

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Ovarian Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT00300586 2019-05-28

IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00048997 2018-06-08

Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer

Phase 3 Completed

356 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02852629 2017-09-18

CBP-Aggrav

Lung Neoplasms

NCT01063400 2012-02-14

Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors

Carcinoma, Non-Small-Cell Lung

NCT01301560 2011-02-23

Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung